Call in to ask questions: 1-800-553-5275
Slides posted at: http://newsroom.mbooth.com/bnl/PressBriefing_10-03/
WHAT:
A two-hour Webcast on leading edge disease research, sponsored by the U.S. Department of Energy's Brookhaven National Laboratory, exclusively for working journalists. Hear directly from scientists at Brookhaven's National Synchrotron Light Source (NSLS), who are using advanced imaging technologies in order to identify and understand a range of diseases.
SCHEDULE:
10 a.m. - Welcome -- John Carter, Director of Community Affairs, U.S. Department of
Energy, Brookhaven Area Office
10:05 a.m. - Overview -- Steven Dierker, Ph.D., Associate Laboratory Director for Light Sources and Chair of the NSLS
10:10 a.m. - Developing Novel Drugs to Treat Infectious Diseases
Walter F. Mangel, Ph.D., Biology Department
Many viruses, bacteria, and parasites continue to baffle modern medicine. But scientists at Brookhaven's NSLS are discovering the biochemical reactions that activate these pathogens and are using this knowledge to develop novel drugs to treat them.
10:35 a.m. - Understanding Microdamage in Osteoporosis Treatment
Lisa Miller, Ph.D., National Synchrotron Light Source
Drugs to treat osteoporosis are now used routinely because they can effectively increase bone density but do they also cause damage to bones? Hear about just-published studies on the microscopic effects of these medications.
11:00 a.m. - Inhibiting the Effects of Botulism
Subramanyam Swaminathan, Ph.D., Biology Department
Botulinum toxin is among the most neurotoxic o
'"/>
Contact: Dennis Tartaglia
dennist@mbooth.com
212-481-7000
M Booth & Associates
21-Oct-2003